CatalystPit

TEVATEVA PHARMACEUTICAL INDUSTRIES LTD

NYSE · Pharmaceutical Preparations
Last close $39.60 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$46.15B
RECENT INSIDER TRADES
  • 2026-09-22 · Savage Brian (Interim Chief Legal Officer) · SELL
  • 2026-09-22 · Savage Brian (Interim Chief Legal Officer) · OTHER
  • 2026-09-22 · MIGNONE ROBERTO (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders722
Shares held789,027,322
Value$21.98B
Percent of shares outstanding67.71%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-03-30 · Alan Armstrong · BUY · $1,001 - $15,000
RECENT NEWS
  • JPMorgan raises Teva price target to $50 on Weltruza approval
  • Oppenheimer raises Teva price target on Weltruza approval
  • Teva gains FDA approval for monthly olanzapine injection
  • Teva wins FDA approval for once-monthly injectable olanzapine
  • Teva presents efficacy and safety data for ecopipam in Tourette syndrome
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS